1-4 of 4
Sherie L. Morrison
Close
Sort by
Journal Articles

In Vivo Efficacy of Anti-CD20-Interferon-Gamma Fusion Protein Against Syngeneic B Cell Lymphoma Is Mediated By Natural Killer Cells

Alex Vasuthasawat, BS, MS, Reiko E Yamada, Kham R Trinh, Neiki Rokni, Sherie L Morrison, PhD, John M. Timmerman, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1575.
https://doi.org/10.1182/blood-2019-131890
Published: 2019
Journal Articles

Antibody-Interferon-Alpha Fusion Protein Therapy for the Treatment of B-Cell Non-Hodgkin Lymphoma: Enhanced ADCC, Inhibition of Proliferation, and In Vivo Eradication of CD20+ Human Lymphomas

John M. Timmerman, MD, Kristopher K Steward, PhD, Reiko E Yamada, Patricia A Young, MD, Dena M. Minning, MD PhD, Raj K Sachdev, PhD, Michael J Gresser, PhD, Sanjay D Khare, PhD, Sherie L Morrison, PhD
Journal: Blood
Blood (2015) 126 (23): 2762.
https://doi.org/10.1182/blood.V126.23.2762.2762
Published: 2015
Journal Articles

Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma

Caiyun Xuan, Kristopher K. Steward, John M. Timmerman, Sherie L. Morrison
Journal: Blood
Blood (2010) 115 (14): 2864–2871.
https://doi.org/10.1182/blood-2009-10-250555
Published: 2010
Journal Articles

Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor

Patrick P. Ng, Gustavo Helguera, Tracy R. Daniels, Simon Z. Lomas, Jose A. Rodriguez, Gary Schiller, Benjamin Bonavida, Sherie L. Morrison, Manuel L. Penichet
Journal: Blood
Blood (2006) 108 (8): 2745–2754.
https://doi.org/10.1182/blood-2006-04-020263
Published: 2006
Includes: Supplemental data